BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 10435593)

  • 1. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta.
    Ghosh PM; Bedolla R; Mikhailova M; Kreisberg JI
    Cancer Res; 2002 May; 62(9):2630-6. PubMed ID: 11980660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth.
    van de Donk NW; Lokhorst HM; Nijhuis EH; Kamphuis MM; Bloem AC
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):429-39. PubMed ID: 15701825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins.
    Macchia M; Jannitti N; Gervasi G; Danesi R
    J Med Chem; 1996 Mar; 39(7):1352-6. PubMed ID: 8691464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin induces apoptosis in malignant mesothelioma cells.
    Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
    Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
    Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein prenylation: key to ras function and cancer intervention?
    Khosravi-Far R; Cox AD; Kato K; Der CJ
    Cell Growth Differ; 1992 Jul; 3(7):461-9. PubMed ID: 1419908
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of the cholesterol pathway and Ras maturation in response to stress.
    Shack S; Gorospe M; Fawcett TW; Hudgins WR; Holbrook NJ
    Oncogene; 1999 Oct; 18(44):6021-8. PubMed ID: 10557091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
    Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation.
    Danesi R; McLellan CA; Myers CE
    Biochem Biophys Res Commun; 1995 Jan; 206(2):637-43. PubMed ID: 7826382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
    Suzuki N; Imai A
    J Obstet Gynaecol; 2010 May; 30(4):404-7. PubMed ID: 20455727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
    Ghosh PM; Mott GE; Ghosh-Choudhury N; Radnik RA; Stapleton ML; Ghidoni JJ; Kreisberg JI
    Biochim Biophys Acta; 1997 Oct; 1359(1):13-24. PubMed ID: 9398081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.
    García-Román N; Alvarez AM; Toro MJ; Montes A; Lorenzo MJ
    Mol Cell Neurosci; 2001 Feb; 17(2):329-41. PubMed ID: 11178870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
    Fernández-Hernando C; Suárez Y; Lasunción MA
    Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.